FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
May 10, 2024 11:06 AM - Stuart Mooney
TREX Earnings Report Highlights Strong Performance
On Thursday, May 9, 2024, TREX reported its earnings with notable figures, marking a significant moment for the company and its stakeholders. The company's earnings per share (EPS) stood at $0.819, surpassing the estimated EPS of $0.72, and achieved a revenue of approximately $373.64 million, exceed...
May 10, 2024 11:00 AM - Gordon Thompson
Cepton, Inc. (NASDAQ:CPTN) Quarterly Earnings Report Anticipation
Cepton, Inc. (CPTN:NASDAQ) is gearing up to share its quarterly earnings report on Monday, May 13, 2024, after the market closes, drawing significant attention from investors and analysts alike. The anticipation is rooted in Wall Street's expectations, where the earnings per share (EPS) are estimate...
May 10, 2024 10:27 AM - Davit Kirakosyan
Novavax Stock Jumps 128% on Sanofi Deal
Novavax (NASDAQ:NVAX) shares surged by 128% intra-day today fueled by a significant multi-billion dollar deal with French pharmaceutical giant Sanofi SA, despite reporting weaker-than-expected financial results for the first quarter of fiscal 2024. The company reported a loss of $1.05 per share for ...
May 10, 2024 10:21 AM - Davit Kirakosyan
Roblox Plunges 22% on Disappointing Guidance, Overshadowing Q1 Beat
Roblox (NYSE:RBLX) reported first-quarter results that exceeded analyst expectations for both earnings and revenue, but disappointing bookings guidance for the second quarter led to a dramatic 22% drop in its share price yesterday. The company posted a Q1 loss of $0.43 per share, which was better th...
May 10, 2024 10:16 AM - Davit Kirakosyan
Victoria's Secret Stock Gains 12% Following Strong Q1 Preannouncement
Victoria's Secret (NYSE:VSCO) saw its shares rise more than 12% in pre-market today following the release of its preliminary Q1 results, which exceeded expectations. The lingerie and beauty retailer announced adjusted earnings per share (EPS) expected to be between $0.07 and $0.12, surpassing both t...
May 10, 2024 10:14 AM - Tony Dante
Xeris Pharmaceuticals (XERS) Receives New Price Target from Piper Sandler
On Friday, May 10, 2024, David Amsellem of Piper Sandler set a new price target for Xeris Pharmaceuticals (XERS) at $3, as reported by StreetInsider. This new target suggests a significant potential upside of 62.43% from its trading price at the time, which was approximately $1.85. This adjustment i...
May 10, 2024 10:14 AM - Davit Kirakosyan
Squarespace Shares Gain 3% Following Mizuho’s Upgrade
Squarespace (NYSE:SQSP) shares rose more than 3% pre-market today after Mizuho analysts upgraded the company to Buy from Neutral, significantly raising the price target to $50.00 from $34.00. The analysts believe Squarespace is poised to significantly exceed consensus estimates, projecting a 22% yea...
